Apogee Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2022 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Apogee Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2022 to Q2 2024.
  • Apogee Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2024 was 56.5M shares, a 1030% increase year-over-year.
  • Apogee Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 25M shares, a 916% increase from 2022.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 56.5M +51.5M +1030% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 50.2M +45.2M +904% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 25M Oct 1, 2023 Dec 31, 2023 10-K 2024-03-05
Q3 2023 41.2M +39.2M +1883% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 5M +3.75M +300% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 5M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q3 2022 2.08M Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 1.25M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.